This activity consists of recorded presentations from the "Essentials of Oncology, Solid Organ and Blood/Marrow Transplant Management for the Health Care Team" held in Scottsdale, AZ on March 20–21, 2017.
Immunotherapy is one of the most exciting areas of new discoveries and treatments for many different types of cancer. Understanding how the immune system works is opening the doors to developing new treatments as a promising new strategy to treat cancer. Different types of immunotherapy include monoclonal antibodies, cancer vaccines, chimeric-antigen receptor (CAR) T-cell therapy and immune-checkpoint inhibitors. This webcast will describe the various types of immunotherapy and outline their clinical applications. In addition, the specific role of immunotherapy in individuals with multiple myeloma will be addressed.

Learning Objectives
At the end of this educational activity, participants should be able to:

• Explain cytokines, cancer vaccines, CAR T-cell therapy and checkpoint inhibitors, adoptive immunotherapy, and biomarkers, and analyze their recent research and clinical applications
• State the role of immunotherapy in multiple myeloma

Presenter
Edward A. Stadtmauer, MD
Section Chief, Hematologic Malignancies
Roseman, Tarte, Harrow, and Shaffer Families' President's
Distinguished Professor
Abramson Cancer Center, Penn Medicine
Philadelphia, PA

Disclosures of Relevant Financial Relationships
In accordance with the ACCME Standards for Commercial Support^SM, OptumHealth Education requires all those involved in the development of activity content to disclose their relevant financial relationships. An individual has a relevant financial relationship if such person (or his/her spouse/partner) has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the activity content over which the individual has control. OptumHealth Education ensures that the content is independent of commercial bias.

Faculty Disclosure
Edward A. Stadtmauer, MD has reported the following: Amgen, Celgene, Jansen, Novartis, Takeda, Teva (Consultant).

Activity Planner Disclosures
Ms. Chart and Ms. Gleason have indicated that they are employees of and own stock in UnitedHealth Group.
Drs. Abecassis, Ryland and Silverstein have no relevant financial relationships to report.

Method of Participation
There are no fees for participating in or receiving credit for this activity.
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

Participants will receive a certificate upon successful completion of the activity, which includes the following:

• Completing the entire activity
• Completing the Pre- and Post-activity Assessments, Activity Evaluation, and Application for Certificate of Credit forms

You must be logged into your account to participate in this activity. Get started by clicking “Begin” and viewing the “CE Info”; then follow the prompts at the bottom of the screen. At the end of the activity, you will be able to view, save or print your certificate of participation. The Area of Practice you indicated in your profile corresponds with your certificate type. A complete listing of all of your activities can be found under “My Account,” “My Activities.”

Method for Calculating CE Credit
CE credit was calculated by the complexity of content.

Accreditation Statement
In support of improving patient care, OptumHealth Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.

Credit Designation Statements
Nurses
The participant will be awarded up to 0.75 contact hour(s) of credit for attendance and completion of supplemental materials.

Nurse Practitioners
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts credit from organizations accredited by the ACCME and ANCC.

Pharmacists
This activity is approved for 0.75 contact hour(s) ([0.075] CEU) in states that recognize ACPE.
Attending the full program will earn 0.75 contact hour(s).
Unique Activity Number(s): JA0007123-0000-18-132-H01-P

Pharmacy Technicians
This activity is approved for 0.75 contact hour(s) ([0.075] CEU) in states that recognize ACPE.
Attending the full program will earn 0.75 contact hour(s).
Unique Activity Number(s): JA0007123-0000-18-132-H01-T

Physicians
OptumHealth Education designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PAs
The American Academy of Physician Assistants (AAPA) accepts credit from organizations accredited by the ACCME.

Case Managers
The Commission for Case Manager Certification has approved this program for a maximum of 0.75 clock hour(s) for Certified Case Managers (CCM). (Please reference Essentials of Oncology, Solid Organ and Blood/Marrow Transplant Management for the Health Care Team, worth a total of 12.50 credits, when contacting CCMC to claim credit for this activity.)

AAPC-Certified Coders
The Commission for Case Manager Certification has approved this program for a maximum of 0.75 clock hour(s) for Certified Case Managers (CCM).

Attendance
A certificate of attendance will be provided to learners upon completion of activity requirements, enabling participants to register with licensing boards or associations that have not been preapproved for credits. To apply for credit types not listed above, participants should use the procedure established by the specific organization with which they wish to obtain credit.

Provided By
This activity is provided by OptumHealth Education.

Commercial Support
There was no commercial support received for this activity.

Hardware/Software Requirements
To view this activity, you will need Internet Explorer 7.0+ or Firefox 3.0+ with Windows Media Player 9+, RealPlayer 12+ or Adobe Flash Player 9+. Be sure to disable any pop-up blocking software prior to beginning this activity.